Woman Of The Year: Merck's Julie Gerberding On 'Three Vs' For Success
Executive Summary
Accepting Healthcare Businesswomen's Association's 2018 Woman of the Year award, Gerberding shares the principles that have guided her career.
You may also be interested in...
MedImmune's Bahija Jallal On Changing The Diversity Narrative
Bahija Jallal, vice president of AstraZeneca and head of MedImmune, told a packed room of mostly female health care employees that in her career she has "followed her heart and the science" to reach goals she had not imagined possible, as she accepted the Healthcare Businesswomen's Association's 2017 Woman of the Year award.
Companies Reveal Hurdles In Providing Drugs Via Expanded Access Programs
GSK, Stealth BioTherapeutics and Blueprint Medicines discuss the difficulties getting participation of physicians, the excessive cost of expanded access, and whether physicians should report research data.
Current Pathways For Rare Disease Drugs Are Not Optimal, US FDA’s Califf Says
Anticipating a ‘tsunami of therapies’ for rare diseases, commissioner says the agency will have to think of creative approaches and employ regulatory flexibility for them. FDA considers copying the oncology center’s Project Facilitate for expanded access to other diseases.